Report Detail
Global Platinum based Cancer Drug Market Growth 2019-2024
- RnM2975325 |
- 18 February, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017.
Asia-Pacific is the largest market, with a sales market share nearly 53% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
According to this study, over the next five years the Platinum based Cancer Drug market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 1650 million by 2024, from US$ 1290 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Platinum based Cancer Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Platinum based Cancer Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Platinum based Cancer Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Cisplatin
Oxaliplatin
Carboplatin
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Platinum based Cancer Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Platinum based Cancer Drug market by identifying its various subsegments.
Focuses on the key global Platinum based Cancer Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Platinum based Cancer Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Platinum based Cancer Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Platinum based Cancer Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Platinum based Cancer Drug Consumption 2014-2024
- 2.1.2 Platinum based Cancer Drug Consumption CAGR by Region
- 2.2 Platinum based Cancer Drug Segment by Type
- 2.2.1 Cisplatin
- 2.2.2 Oxaliplatin
- 2.2.3 Carboplatin
- 2.2.4 Other
- 2.3 Platinum based Cancer Drug Consumption by Type
- 2.3.1 Global Platinum based Cancer Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Platinum based Cancer Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Platinum based Cancer Drug Sale Price by Type (2014-2019)
- 2.4 Platinum based Cancer Drug Segment by Application
- 2.4.1 Colorectal Cancer
- 2.4.2 Ovarian Cancer
- 2.4.3 Lung Cancer
- 2.4.4 Other
- 2.5 Platinum based Cancer Drug Consumption by Application
- 2.5.1 Global Platinum based Cancer Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Platinum based Cancer Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Platinum based Cancer Drug Sale Price by Application (2014-2019)
3 Global Platinum based Cancer Drug by Players
- 3.1 Global Platinum based Cancer Drug Sales Market Share by Players
- 3.1.1 Global Platinum based Cancer Drug Sales by Players (2017-2019)
- 3.1.2 Global Platinum based Cancer Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Platinum based Cancer Drug Revenue Market Share by Players
- 3.2.1 Global Platinum based Cancer Drug Revenue by Players (2017-2019)
- 3.2.2 Global Platinum based Cancer Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Platinum based Cancer Drug Sale Price by Players
- 3.4 Global Platinum based Cancer Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Platinum based Cancer Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Platinum based Cancer Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Platinum based Cancer Drug by Regions
- 4.1 Platinum based Cancer Drug by Regions
- 4.1.1 Global Platinum based Cancer Drug Consumption by Regions
- 4.1.2 Global Platinum based Cancer Drug Value by Regions
- 4.2 Americas Platinum based Cancer Drug Consumption Growth
- 4.3 APAC Platinum based Cancer Drug Consumption Growth
- 4.4 Europe Platinum based Cancer Drug Consumption Growth
- 4.5 Middle East & Africa Platinum based Cancer Drug Consumption Growth
5 Americas
- 5.1 Americas Platinum based Cancer Drug Consumption by Countries
- 5.1.1 Americas Platinum based Cancer Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Platinum based Cancer Drug Value by Countries (2014-2019)
- 5.2 Americas Platinum based Cancer Drug Consumption by Type
- 5.3 Americas Platinum based Cancer Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Platinum based Cancer Drug Consumption by Countries
- 6.1.1 APAC Platinum based Cancer Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Platinum based Cancer Drug Value by Countries (2014-2019)
- 6.2 APAC Platinum based Cancer Drug Consumption by Type
- 6.3 APAC Platinum based Cancer Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Platinum based Cancer Drug by Countries
- 7.1.1 Europe Platinum based Cancer Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Platinum based Cancer Drug Value by Countries (2014-2019)
- 7.2 Europe Platinum based Cancer Drug Consumption by Type
- 7.3 Europe Platinum based Cancer Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Platinum based Cancer Drug by Countries
- 8.1.1 Middle East & Africa Platinum based Cancer Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Platinum based Cancer Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Platinum based Cancer Drug Consumption by Type
- 8.3 Middle East & Africa Platinum based Cancer Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Platinum based Cancer Drug Distributors
- 10.3 Platinum based Cancer Drug Customer
11 Global Platinum based Cancer Drug Market Forecast
- 11.1 Global Platinum based Cancer Drug Consumption Forecast (2019-2024)
- 11.2 Global Platinum based Cancer Drug Forecast by Regions
- 11.2.1 Global Platinum based Cancer Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Platinum based Cancer Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Platinum based Cancer Drug Forecast by Type
- 11.8 Global Platinum based Cancer Drug Forecast by Application
12 Key Players Analysis
- 12.1 Sanofi
- 12.1.1 Company Details
- 12.1.2 Platinum based Cancer Drug Product Offered
- 12.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sanofi News
- 12.2 Hengrui Medicine
- 12.2.1 Company Details
- 12.2.2 Platinum based Cancer Drug Product Offered
- 12.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Hengrui Medicine News
- 12.3 ASK Pharma
- 12.3.1 Company Details
- 12.3.2 Platinum based Cancer Drug Product Offered
- 12.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 ASK Pharma News
- 12.4 Yi Bai Pharmaceutical
- 12.4.1 Company Details
- 12.4.2 Platinum based Cancer Drug Product Offered
- 12.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Yi Bai Pharmaceutical News
- 12.5 Qilu Pharmaceutical
- 12.5.1 Company Details
- 12.5.2 Platinum based Cancer Drug Product Offered
- 12.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Qilu Pharmaceutical News
- 12.6 Teva
- 12.6.1 Company Details
- 12.6.2 Platinum based Cancer Drug Product Offered
- 12.6.3 Teva Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Teva News
- 12.7 Pfizer
- 12.7.1 Company Details
- 12.7.2 Platinum based Cancer Drug Product Offered
- 12.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Pfizer News
- 12.8 Dr Reddy's Laboratories
- 12.8.1 Company Details
- 12.8.2 Platinum based Cancer Drug Product Offered
- 12.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Dr Reddy's Laboratories News
- 12.9 Mylan
- 12.9.1 Company Details
- 12.9.2 Platinum based Cancer Drug Product Offered
- 12.9.3 Mylan Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Mylan News
- 12.10 Sun Pharma
- 12.10.1 Company Details
- 12.10.2 Platinum based Cancer Drug Product Offered
- 12.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Sun Pharma News
- 12.11 Novartis
- 12.12 Debiopharm
- 12.13 Accord Healthcare
- 12.14 SK Chemicals
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Platinum based Cancer Drug . Industry analysis & Market Report on Platinum based Cancer Drug is a syndicated market report, published as Global Platinum based Cancer Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Platinum based Cancer Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
